The present invention relates to novel compounds that are partial or full A1 adenosine receptor agonists, and to their use in treating mammals for various disease states, including cardiovascular diseases, in particular arrhythmia, and {TAIL ~ the prevention} of sudden death resulting from arrhythmia, ischemia, CNS disorders including {HEAD ~ pain}, epilepsy, emesis, and metabolic disorders including diabetes and obesity 
The present invention relates to novel compounds that are partial or full A1 adenosine receptor agonists , and to their use in treating mammals for various disease states , including cardiovascular diseases , in particular arrhythmia , and { TAIL ~ the prevention } of sudden death resulting from arrhythmia , ischemia , CNS disorders including { HEAD ~ pain } , epilepsy , emesis , and metabolic disorders including diabetes and obesity
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH